1h Free Analyst Time
The regenerative medicine market is forecasted to grow by USD 70.11 billion during 2023-2028, accelerating at a CAGR of 23.31% during the forecast period. The report on the regenerative medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increasing support from public and private healthcare organizations, and increasing adoption of stem cell therapy.
The regenerative medicine market is segmented as below:
By Application
- Oncology
- Musculoskeletal
- Dermatology
- Immunology and inflammation and others
By Technology
- Cell
- tissue-based
- Gene therapy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the regenerative medicine market covers the following areas:
- Regenerative medicine market sizing
- Regenerative medicine market forecast
- Regenerative medicine market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Technology
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
New Report Released: - Global Regenerative Medicine Market 2018-2022.The author of the report recognizes the following companies as the key players in the global regenerative medicine market: ALLERGAN, Integra LifeSciences, Medtronic, MiMedx Group, Organogenesis, and Zimmer Biomet.
Commenting on the report, an analyst from the research team said: “One trend in the market is emerging technological advances. With the growing demand, vendors in the stem cell therapy market focus on investing in technological advancements such as using regenerated tracheas for transplant and 3D bioprinting to survive in this competitive market.”
According to the report, one driver in the market is increasing prevalence of chronic diseases. According to the Centers for Disease Control and Prevention (CDC), over 117 million individuals in the US had one of more chronic health conditions in 2012. Moreover, there is also an increase in the prevalence of acute wounds such as surgical and traumatic wounds across the globe and it has been observed that the global prevalence of surgical wounds was about 135,000 in 2016.
Further, the report states that one challenge in the market is uncertain regulatory approval. Cell therapy, gene therapy, and tissue engineering have been under development for several decades. However, their successful clinical application is still considered to be a recent phenomenon in both developed and developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Baxter International Inc.
- Becton Dickinson and Co.
- Cook Group Inc.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- Integra Lifesciences Corp.
- Johnson and Johnson
- Medtronic Plc
- Merck and Co. Inc.
- Mesoblast Ltd.
- MiMedx Group Inc.
- Novartis AG
- Nuvasive Inc.
- Organogenesis Holdings Inc.
- Smith and Nephew plc
- Thermo Fisher Scientific Inc.
- Vericel Corp.
- Zimmer Biomet Holdings Inc.
![Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) - Forecast to 2028 - Product Image](http://www.researchandmarkets.com/product_images/11963/11963057_60px_jpg/regenerative_medicine_market.jpg)
